Navigation Links
Bio-Tissue Reaches Major Milestone
Date:6/1/2011

MIAMI, June 1, 2011 /PRNewswire/ -- Bio-Tissue, the industry leader in Ophthalmic tissue products, announced today that it has shipped over 7,500 ProKera® units since the product's inception.  ProKera® is the only medical device that can provide wound healing to over 350,000 annual cases of patients afflicted with damaged ocular surfaces. ProKera® is a class II medical device composed of cryopreserved amniotic membrane tissue clipped into a thermoplastic ring set.   "We are excited to be able to provide ProKera® to the patient community that is in dire need of this innovative technology," stated Amy Tseng, President, CEO, Bio-Tissue, Inc.  "We are also encouraged by the support we have received to allow this procedure to be performed and reimbursed in the physician's office setting," concluded Tseng.

ProKera® combines the functionality of a symblepharon ring with the biologic actions of cryopreserved amniotic membrane to create a unique treatment option for patients presented with corneal abrasions, scarring, erosion, infectious disease and chemical/thermal burns. "ProKera® is a safe and effective product that allows me to provide my patients with unparalleled clinical results without the invasiveness of surgery," said Dr. George Rosenwasser of Central Pennsylvania Eye Institute.  "In addition, the ProKera® device configuration enables easy insertion in the office, hospital bedside, or following other surgical procedures."      

About Bio-Tissue:

Bio-Tissue is the industry leader in ophthalmic tissue products and is engaged in the procurement, processing, storage, and distribution of cryopreserved human amniotic membrane.  Bio-Tissue's patented CryoTek™ method ensures that the tissue retains biologic activity to promote wound healing as well as superior handling characteristics.  Bio-Tissue is headquartered in Miami, FL and services customers shared with companies such as Alcon, Abbott Labs and Bausch & Lomb.  For more information, please visit our website at www.biotissue.com


'/>"/>
SOURCE Bio-Tissue
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Ascension Orthopedics Reaches Milestone With Distribution of 40,000 PyroCarbon Implants
2. Onda Reaches Distribution Agreement with S&V Korea to Expand Presence in South Korea
3. Terumo Cardiovascular Systems Reaches Agreement on Terms of Consent Decree With FDA Regarding Quality System Improvements
4. Ajinomoto Co.s Capsiate Natura® Reaches New Milestone
5. meridianEMR Reaches 1,000 Urology Providers and Celebrates the Best Sales Month in Company History
6. United Seating & Mobility Reaches Agreement With Alliance Homecare Equipment to Acquire its Complex Mobility Business
7. Cayenne Medical, Inc. Reaches 50,000 Implant Milestone
8. AAPC Reaches 100,000 Members
9. Generex Reaches Agreement to Acquire 51% Stake in Global Medical Direct, a Nationwide Durable Medical Equipment and Pharmaceutical Provider Specializing in Direct-to-Consumer Diabetes Supplies
10. Watson Reaches Settlement with Endo Over Opana® ER
11. U.S. Navy Reaches Agreement to Purchase QBC STAR Hematology Analyzers for Use on its Surface Fleet
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... 2016 On Thursday, Feb. 11, 2016, surgeons ... David,s North Austin Medical Center successfully completed the first ... ® Surgical System with Trumpf Medical,s advanced operating ... Lakshman , M.D., colorectal surgeon at the Texas Institute ... Table Motion technology, which seamlessly combines the da Vinci ...
(Date:2/12/2016)... , Feb. 12, 2016  Aralez Pharmaceuticals Inc. (Nasdaq: ... announced the Company will ring the Nasdaq Closing Bell ... New York at 4:00 p.m. ET on ... Aralez. Adrian Adams , will perform ... 3:50 to 4:00 p.m. ET.  A live webcast will ...
(Date:2/12/2016)... , Feb. 12, 2016  Apellis Pharmaceuticals, ... a $47.1 million Series D preferred stock ... Management, Hillhouse Capital Group and venBio Global ... Investments, AJU IB Investment, and Epidarex Capital. The ... to further advance clinical trials in the ...
Breaking Medicine Technology:
(Date:2/12/2016)... ... February 12, 2016 , ... Fixed Dose ... – 3:00 p.m. EST, http://www.fdanews.com/fixeddosecombination , Fixed dose ... products, garnering increased attention from all stakeholders in the development of new chemical ...
(Date:2/12/2016)... ... February 12, 2016 , ... The ThedaCare Center for Healthcare ... Hospital on April 5-7. The series is a multi-day, multi-workshop event designed to ... cover a broad range of topics, including coaching skills, the scientific method of ...
(Date:2/12/2016)... ... 12, 2016 , ... The Jones Agency, a family owned insurance company with ... a cooperative charity drive with the Tarrant Area Food Bank in the hopes of ... families in need, the Tarrant County Food Bank offers hope and security to the ...
(Date:2/12/2016)... ... 2016 , ... Miami Dental Specialists is excited to bring patients the choice ... in January, Miami Dental Specialists will offer the non-metal implants as a safe, holistic ... be chosen by the dental implant manufacturer, Straumann, to bring this cutting-edge technology to ...
(Date:2/12/2016)... ... February 12, 2016 , ... Atlantic Information Services, ... Plans and PBMs,” an upcoming Feb. 24 webinar that will discuss ways health ... therapeutic categories, such as the $1,000-per-pill hepatitis C treatment Sovaldi and high-cost PCSK9 ...
Breaking Medicine News(10 mins):